Marché mondial du traitement du syndrome de Churg-Strauss – Tendances et prévisions du secteur jusqu’en 2028

Analyse et perspectives du marché : marché mondial du traitement du syndrome de Churg-Strauss

Le marché du traitement du syndrome de Churg-Strauss devrait connaître une croissance potentielle de 4,80 % au cours de la période de prévision de 2021 à 2028. L'augmentation des investissements dans la recherche et le développement est le facteur responsable de la croissance du marché.

Le syndrome de Churg-Strauss, également connu sous le nom de granulomatose éosinophile avec polyangéite, est un type de trouble qui provoque une inflammation des vaisseaux sanguins. Cela bloque le flux sanguin vers les organes et tissus essentiels. Parfois, cela entraîne également des lésions tissulaires permanentes. L'asthme est reconnu comme le signe le plus courant du syndrome de Churg-Strauss. 

L'augmentation rapide des cas de syndrome de Churg-Strauss et d'autres réactions allergiques devrait accélérer la croissance du marché au cours de la période de prévision de 2021 à 2028. De même, l'augmentation de l'incidence de l'asthme dans le monde et l'augmentation rapide de la population gériatrique devraient également favoriser la croissance du marché du traitement du syndrome de Churg-Strauss. En outre, l'augmentation des cas de syndrome de Churg-Strauss chez les enfants et l'augmentation des troubles liés au système immunitaire devraient également stimuler le taux de croissance du marché.

En outre, l'augmentation des dépenses publiques pour la douleur et l'inflammation des sinus, le grand nombre de personnes consultant un médecin pour un problème de réaction allergique et l'augmentation des activités de R&D sont susceptibles de créer diverses nouvelles opportunités qui auront un impact sur la croissance du marché du traitement du syndrome de Churg-Strauss au cours de la période de prévision de 2021 à 2028.

However, the unfavorable reimbursement scenario and lack of awareness about the autoimmune disorder amongst people are expected to act as major restraints towards the growth of the churg-strauss syndrome treatment market, whereas the no specific tests available for diagnosis for churg strauss syndrome can challenge the growth of the target market in the above mentioned forecast period.

This churg-strauss syndrome treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the churg-strauss syndrome treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Churg-Strauss Syndrome Treatment Market Scope and Market Size

Churg-strauss syndrome treatment market is segmented on the basis of indication, diagnosis, treatment, route of administration, distribution channel and end users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• Based on indication, the churg-strauss syndrome treatment market can be segmented into acute ischemic stroke, cerebral insufficiency, alzheimer's disease, attention deficit-hyperactive disorder (ADHD) and others.
• On the basis of diagnosis, the churg-strauss syndrome treatment market can be segmented into blood test, imaging, biopsy, chest X-ray and CT scan.
• On the basis of treatment, the churg-strauss syndrome treatment market can be segmented into biologics, immunoglobulin, vaccines, steroid, corticosteroid, immunosuppressive drugs and others.
• The route of administration segment of the churg-strauss syndrome treatment market can be segmented into oral and injectable.
• Based on distribution channel, the churg-strauss syndrome treatment market can be segmented into hospital pharmacies, retail pharmacies and mail order pharmacies.
• On the basis of end users, the churg-strauss syndrome treatment market can be segmented into hospitals, laboratories, clinics, therapeutic usage, and others.

Churg-Strauss Syndrome Treatment Market Country Level Analysis

Churg-strauss syndrome treatment market is analyzed and market size information is provided by country by indication, diagnosis, treatment, route of administration, distribution channel and end users as referenced above.

The countries covered in the churg-strauss syndrome treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America leads the churg-strauss syndrome treatment market due to rapid rise in the asthma patients, change in environmental conditions and increase in the allergic reaction. Asia-Pacific region is expected to expand at a significant growth rate in the forecast period of 2021 to 2028 because of the increase in the prevalence of immunosuppressant disease as well as the hyper-eosinophilia related problems and rise in the incidences of granulomatosis.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Churg-strauss syndrome treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Churg-Strauss Syndrome Treatment Market Share Analysis

Churg-strauss syndrome treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to churg-strauss syndrome treatment market.

Les principaux acteurs couverts dans le rapport sur le marché du traitement du syndrome de Churg-Strauss sont Heron Therapeutics, Inc., Grifols, SA, GlaxoSmithKline plc, Novartis AG, Hikma Pharmaceuticals PLC, Avalon Pharma Private Limited, F. Hoffmann-La Roche Ltd., AstraZeneca, LGM Pharma et Taj Pharma, entre autres acteurs nationaux et mondiaux. Les données sur les parts de marché du traitement du syndrome de Churg-Strauss sont disponibles séparément pour le monde, l'Amérique du Nord, l'Amérique du Sud, l'Europe, l'Asie-Pacifique (APAC) et le Moyen-Orient et l'Afrique (MEA). Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.

SKU-63108